View in EDS HTML Full Text PDF Full Text

Real-world Effectiveness of Adjuvanted RSVPreF3 Vaccine in Preventing RSV-associated Lower Respiratory Tract Disease Hospitalization in Adults ≥60 Years of Age: Early Results From a Test-negative Design Analysis.

Saved in:
Bibliographic Details
Title: Real-world Effectiveness of Adjuvanted RSVPreF3 Vaccine in Preventing RSV-associated Lower Respiratory Tract Disease Hospitalization in Adults ≥60 Years of Age: Early Results From a Test-negative Design Analysis.
Authors: Ku JH; Center for Integrated Health Care Research, Kaiser Permanente Hawaii, Honolulu, Hawaii, USA.; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA.; Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, California, USA., Qian L; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA., Sy LS; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA., Ackerson BK; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA., Rayens E; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA., Luo Y; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA., Qiu S; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA., Xu L; Medhealth Analytics Inc., Sugar Land, Texas, USA., Lee GS; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA., Modha PP; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA., Hoke CF; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA.; Clinical Insights and Analytics, Atropos Health, NewYork, New York, USA., Joe C; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA., Amundsen BI; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA., Pirçon JY; GSK, Wavre, Belgium., Harrington L; GSK, Wavre, Belgium., Lecrenier N; GSK, Wavre, Belgium., Singer D; GSK, Philadelphia, Pennsylvania, USA., La EM; GSK, Philadelphia, Pennsylvania, USA., Allmon AG; GSK, Durham, North Carolina, USA., Luyts D; GSK, Wavre, Belgium., Tseng HF; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA.; Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, California, USA.
Source: Open forum infectious diseases [Open Forum Infect Dis] 2026 May 05; Vol. 13 (5), pp. ofag279. Date of Electronic Publication: 2026 May 05 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Published by Oxford University Press on behalf of the Infectious Diseases Society of America Country of Publication: United States NLM ID: 101637045 Publication Model: eCollection Cited Medium: Print ISSN: 2328-8957 (Print) Linking ISSN: 23288957 NLM ISO Abbreviation: Open Forum Infect Dis Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42169689
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Real-world Effectiveness of Adjuvanted RSVPreF3 Vaccine in Preventing RSV-associated Lower Respiratory Tract Disease Hospitalization in Adults ≥60 Years of Age: Early Results From a Test-negative Design Analysis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ku+JH%22">Ku JH</searchLink>; Center for Integrated Health Care Research, Kaiser Permanente Hawaii, Honolulu, Hawaii, USA.; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA.; Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, California, USA.<br /><searchLink fieldCode="AU" term="%22Qian+L%22">Qian L</searchLink>; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA.<br /><searchLink fieldCode="AU" term="%22Sy+LS%22">Sy LS</searchLink>; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA.<br /><searchLink fieldCode="AU" term="%22Ackerson+BK%22">Ackerson BK</searchLink>; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA.<br /><searchLink fieldCode="AU" term="%22Rayens+E%22">Rayens E</searchLink>; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA.<br /><searchLink fieldCode="AU" term="%22Luo+Y%22">Luo Y</searchLink>; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA.<br /><searchLink fieldCode="AU" term="%22Qiu+S%22">Qiu S</searchLink>; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA.<br /><searchLink fieldCode="AU" term="%22Xu+L%22">Xu L</searchLink>; Medhealth Analytics Inc., Sugar Land, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Lee+GS%22">Lee GS</searchLink>; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA.<br /><searchLink fieldCode="AU" term="%22Modha+PP%22">Modha PP</searchLink>; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA.<br /><searchLink fieldCode="AU" term="%22Hoke+CF%22">Hoke CF</searchLink>; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA.; Clinical Insights and Analytics, Atropos Health, NewYork, New York, USA.<br /><searchLink fieldCode="AU" term="%22Joe+C%22">Joe C</searchLink>; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA.<br /><searchLink fieldCode="AU" term="%22Amundsen+BI%22">Amundsen BI</searchLink>; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA.<br /><searchLink fieldCode="AU" term="%22Pirçon+JY%22">Pirçon JY</searchLink>; GSK, Wavre, Belgium.<br /><searchLink fieldCode="AU" term="%22Harrington+L%22">Harrington L</searchLink>; GSK, Wavre, Belgium.<br /><searchLink fieldCode="AU" term="%22Lecrenier+N%22">Lecrenier N</searchLink>; GSK, Wavre, Belgium.<br /><searchLink fieldCode="AU" term="%22Singer+D%22">Singer D</searchLink>; GSK, Philadelphia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22La+EM%22">La EM</searchLink>; GSK, Philadelphia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Allmon+AG%22">Allmon AG</searchLink>; GSK, Durham, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Luyts+D%22">Luyts D</searchLink>; GSK, Wavre, Belgium.<br /><searchLink fieldCode="AU" term="%22Tseng+HF%22">Tseng HF</searchLink>; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA.; Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, California, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101637045%22">Open forum infectious diseases</searchLink> [Open Forum Infect Dis] 2026 May 05; Vol. 13 (5), pp. ofag279. <i>Date of Electronic Publication: </i>2026 May 05 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Published+by+Oxford+University+Press+on+behalf+of+the+Infectious+Diseases+Society+of+America%22">Published by Oxford University Press on behalf of the Infectious Diseases Society of America </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101637045 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2328-8957 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223288957%22">23288957 </searchLink><i>NLM ISO Abbreviation: </i>Open Forum Infect Dis <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42169689
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/ofid/ofag279
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: ofag279
    Titles:
      – TitleFull: Real-world Effectiveness of Adjuvanted RSVPreF3 Vaccine in Preventing RSV-associated Lower Respiratory Tract Disease Hospitalization in Adults ≥60 Years of Age: Early Results From a Test-negative Design Analysis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ku JH
      – PersonEntity:
          Name:
            NameFull: Qian L
      – PersonEntity:
          Name:
            NameFull: Sy LS
      – PersonEntity:
          Name:
            NameFull: Ackerson BK
      – PersonEntity:
          Name:
            NameFull: Rayens E
      – PersonEntity:
          Name:
            NameFull: Luo Y
      – PersonEntity:
          Name:
            NameFull: Qiu S
      – PersonEntity:
          Name:
            NameFull: Xu L
      – PersonEntity:
          Name:
            NameFull: Lee GS
      – PersonEntity:
          Name:
            NameFull: Modha PP
      – PersonEntity:
          Name:
            NameFull: Hoke CF
      – PersonEntity:
          Name:
            NameFull: Joe C
      – PersonEntity:
          Name:
            NameFull: Amundsen BI
      – PersonEntity:
          Name:
            NameFull: Pirçon JY
      – PersonEntity:
          Name:
            NameFull: Harrington L
      – PersonEntity:
          Name:
            NameFull: Lecrenier N
      – PersonEntity:
          Name:
            NameFull: Singer D
      – PersonEntity:
          Name:
            NameFull: La EM
      – PersonEntity:
          Name:
            NameFull: Allmon AG
      – PersonEntity:
          Name:
            NameFull: Luyts D
      – PersonEntity:
          Name:
            NameFull: Tseng HF
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 05
              M: 05
              Text: 2026 May 05
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 2328-8957
          Numbering:
            – Type: volume
              Value: 13
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Open forum infectious diseases
              Type: main
ResultId 1